MOED model

1. MOED model predicts hepatocellular carcinoma in humans (91.9% sensitivity, 98.4% specificity).

   “In the independent validation set, the locked MOED exhibited 91.9% (95% CI: 86.5%-95.6%) overall sensitivity, 83.3% (95% CI: 51.6%-97.9%) stage 0 sensitivity, and 98.4% overall specificity”

   Humansindependent validation setperipheral bloodn = 797

   Liquid biopsy-based multi-omics approach for early detection of hepatocellular carcinoma (ASCEND-Hep): a multiphase prospective development and validation study

   BMC medicine·6 Jul 2026

More on Hepatocellular carcinoma